Pradžia › Geltonosios dėmės degeneracija › Ilinoisas
Geltonosios dėmės degeneracija klinikiniai tyrimai Ilinoisas
13 tyrimai dėl Geltonosios dėmės degeneracija ieško dalyvių vietose Ilinoisas.
Miestai Ilinoisas
Oficialus tyrimo tekstas (anglų kalba)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Illinois Retina Associates, Oak Park
- Springfield Clinic, Springfield
Renkami dalyviai2/3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- University Retina, Lemont
Renkami dalyviai2/3 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06635148A Study in Adults With Geographic Atrophy
- University Retina and Macula Associates, P.C., Lemont
Renkami dalyviai2 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- University of Illinois at Chicago, Chicago
- Retinal Vitreal Consultants, Chicago
- The University of Chicago, Chicago
- ir dar 3
Renkami dalyviai3 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-09-18 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Northwestern Medical Group, Chicago
- The University of Chicago Medicine Duchossois Center for Advanced Medicine, Chicago
- Retina Associates, Ltd., Elmhurst
- ir dar 1
Renkami dalyviai2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- University Retina and Macula Associates, Oak Forest
Renkami dalyviai1 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT03178149A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
- University Retina and Macula Associates, Oak Forest
Renkami dalyviaiStebimasis tyrimas
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07144137Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- University Retina & Macula Associates, Lemont
Renkami dalyviai
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-08-26 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Illinois Chicago - UI Health, Chicago
Renkami dalyviaiStebimasis tyrimas
Amžius 6 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT074255744D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- University Retina and Macula Associates, Oak Forest
Renkami dalyviai1/2 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-21 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Illinois Retina Associates, Joliet
- University Retina & Macula Associates, P.C., Lemont
Renkami dalyviai2/3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-06 · NCT07496567Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 179, Lemont
Renkami dalyviai2 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT07630649Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Retina Associates, Ltd., Elmhurst
- University Retina and Macula Associates, PC, Oak Forest
- Illinois Retina Associates, Oak Park
- ir dar 1
Renkami dalyviai3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-04-16 · NCT07064759Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.